alpha by @dming

Meridian Rank

18 stocks · as of 2026-10-27

M 100

Filters2

Rank	Ticker	Company	MomentumThe Momentum score, from 0 to 100.	QualityHow profitable and financially sound the business is. Percentile, from 0 to 100.	MomentumHow strongly the share price has been rising. Percentile, from 0 to 100.	GrowthHow fast the business is growing. Percentile, from 0 to 100.	ValuationHow cheap the shares are for what the business earns, sells and owns. Percentile, from 0 to 100.	ExpectationsHow the latest earnings compared with what was expected. Percentile, from 0 to 100.
1	MRNAOpen MRNA on Seeking Alpha in a new tab.80% of the way from the 52-week low to the 52-week high.	ModernaHealthcare Biotechnology	100	Quality: 4th percentile	Momentum: 100th percentile	Growth: 0th percentile	Valuation: 3rd percentile	Expectations: 32nd percentile	QualityQuality: 4th percentileMomentumMomentum: 100th percentileGrowthGrowth: 0th percentileValuationValuation: 3rd percentileExpectationsExpectations: 32nd percentile
2	TXGOpen TXG on Seeking Alpha in a new tab.73% of the way from the 52-week low to the 52-week high.	10x GenomicsHealthcare Biotechnology	100	Quality: 79th percentile	Momentum: 99th percentile	Growth: 4th percentile	Valuation: 7th percentile	Expectations: 93rd percentile	QualityQuality: 79th percentileMomentumMomentum: 99th percentileGrowthGrowth: 4th percentileValuationValuation: 7th percentileExpectationsExpectations: 93rd percentile
3	TWSTOpen TWST on Seeking Alpha in a new tab.70% of the way from the 52-week low to the 52-week high.	Twist BioscienceHealthcare Biotechnology	100	Quality: 44th percentile	Momentum: 99th percentile	Growth: 47th percentile	Valuation: 3rd percentile	Expectations: 6th percentile	QualityQuality: 44th percentileMomentumMomentum: 99th percentileGrowthGrowth: 47th percentileValuationValuation: 3rd percentileExpectationsExpectations: 6th percentile
29	HALOOpen HALO on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high.	Halozyme TherapeuticsHealthcare Biotechnology	96	Quality: 27th percentile	Momentum: 96th percentile	Growth: 47th percentile	Valuation: 28th percentile	Expectations: 89th percentile	QualityQuality: 27th percentileMomentumMomentum: 96th percentileGrowthGrowth: 47th percentileValuationValuation: 28th percentileExpectationsExpectations: 89th percentile
68	RVMDOpen RVMD on Seeking Alpha in a new tab.77% of the way from the 52-week low to the 52-week high.	Revolution MedicinesHealthcare Biotechnology	90	No data	Momentum: 90th percentile	Growth: 15th percentile	Valuation: 2nd percentile	Expectations: 1st percentile	QualityNo dataMomentumMomentum: 90th percentileGrowthGrowth: 15th percentileValuationValuation: 2nd percentileExpectationsExpectations: 1st percentile
73	TECHOpen TECH on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high.	Bio-TechneHealthcare Biotechnology	90	Quality: 86th percentile	Momentum: 89th percentile	Growth: 92nd percentile	Valuation: 20th percentile	Expectations: 17th percentile	QualityQuality: 86th percentileMomentumMomentum: 89th percentileGrowthGrowth: 92nd percentileValuationValuation: 20th percentileExpectationsExpectations: 17th percentile
81	EXELOpen EXEL on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high.	ExelixisHealthcare Biotechnology	89	Quality: 96th percentile	Momentum: 88th percentile	Growth: 25th percentile	Valuation: 57th percentile	Expectations: 55th percentile	QualityQuality: 96th percentileMomentumMomentum: 88th percentileGrowthGrowth: 25th percentileValuationValuation: 57th percentileExpectationsExpectations: 55th percentile
89	INCYOpen INCY on Seeking Alpha in a new tab.67% of the way from the 52-week low to the 52-week high.	IncyteHealthcare Biotechnology	87	Quality: 62nd percentile	Momentum: 87th percentile	Growth: 9th percentile	Valuation: 82nd percentile	Expectations: 94th percentile	QualityQuality: 62nd percentileMomentumMomentum: 87th percentileGrowthGrowth: 9th percentileValuationValuation: 82nd percentileExpectationsExpectations: 94th percentile
123	VRTXOpen VRTX on Seeking Alpha in a new tab.75% of the way from the 52-week low to the 52-week high.	Vertex PharmaceuticalsHealthcare Biotechnology	83	Quality: 58th percentile	Momentum: 82nd percentile	Growth: 1st percentile	Valuation: 28th percentile	Expectations: 15th percentile	QualityQuality: 58th percentileMomentumMomentum: 82nd percentileGrowthGrowth: 1st percentileValuationValuation: 28th percentileExpectationsExpectations: 15th percentile
200	BMRNOpen BMRN on Seeking Alpha in a new tab.28% of the way from the 52-week low to the 52-week high.	BioMarin PharmaceuticalHealthcare Biotechnology	72	Quality: 13th percentile	Momentum: 71st percentile	Growth: 0th percentile	Valuation: 68th percentile	Expectations: 89th percentile	QualityQuality: 13th percentileMomentumMomentum: 71st percentileGrowthGrowth: 0th percentileValuationValuation: 68th percentileExpectationsExpectations: 89th percentile
216	NBIXOpen NBIX on Seeking Alpha in a new tab.37% of the way from the 52-week low to the 52-week high.	Neurocrine BiosciencesHealthcare Biotechnology	69	Quality: 72nd percentile	Momentum: 69th percentile	Growth: 86th percentile	Valuation: 63rd percentile	Expectations: 95th percentile	QualityQuality: 72nd percentileMomentumMomentum: 69th percentileGrowthGrowth: 86th percentileValuationValuation: 63rd percentileExpectationsExpectations: 95th percentile
315	REGNOpen REGN on Seeking Alpha in a new tab.85% of the way from the 52-week low to the 52-week high.	Regeneron PharmaceuticalsHealthcare Biotechnology	55	Quality: 39th percentile	Momentum: 55th percentile	Growth: 38th percentile	Valuation: 61st percentile	Expectations: 93rd percentile	QualityQuality: 39th percentileMomentumMomentum: 55th percentileGrowthGrowth: 38th percentileValuationValuation: 61st percentileExpectationsExpectations: 93rd percentile
372	MDGLOpen MDGL on Seeking Alpha in a new tab.21% of the way from the 52-week low to the 52-week high.	Madrigal PharmaceuticalsHealthcare Biotechnology	47	Quality: 75th percentile	Momentum: 47th percentile	Growth: 39th percentile	Valuation: 6th percentile	Expectations: 88th percentile	QualityQuality: 75th percentileMomentumMomentum: 47th percentileGrowthGrowth: 39th percentileValuationValuation: 6th percentileExpectationsExpectations: 88th percentile
451	BBIOOpen BBIO on Seeking Alpha in a new tab.34% of the way from the 52-week low to the 52-week high.	BridgeBio PharmaHealthcare Biotechnology	36	No data	Momentum: 35th percentile	Growth: 99th percentile	Valuation: 0th percentile	Expectations: 2nd percentile	QualityNo dataMomentumMomentum: 35th percentileGrowthGrowth: 99th percentileValuationValuation: 0th percentileExpectationsExpectations: 2nd percentile
574	INSMOpen INSM on Seeking Alpha in a new tab.4% of the way from the 52-week low to the 52-week high.	InsmedHealthcare Biotechnology	18	Quality: 20th percentile	Momentum: 18th percentile	Growth: 98th percentile	Valuation: 1st percentile	Expectations: 97th percentile	QualityQuality: 20th percentileMomentumMomentum: 18th percentileGrowthGrowth: 98th percentileValuationValuation: 1st percentileExpectationsExpectations: 97th percentile
590	UTHROpen UTHR on Seeking Alpha in a new tab.91% of the way from the 52-week low to the 52-week high.	United TherapeuticsHealthcare Biotechnology	16	Quality: 69th percentile	Momentum: 16th percentile	Growth: 19th percentile	Valuation: 54th percentile	Expectations: 52nd percentile	QualityQuality: 69th percentileMomentumMomentum: 16th percentileGrowthGrowth: 19th percentileValuationValuation: 54th percentileExpectationsExpectations: 52nd percentile
599	ALNYOpen ALNY on Seeking Alpha in a new tab.10% of the way from the 52-week low to the 52-week high.	Alnylam PharmaceuticalsHealthcare Biotechnology	15	Quality: 96th percentile	Momentum: 14th percentile	Growth: 97th percentile	Valuation: 23rd percentile	Expectations: 3rd percentile	QualityQuality: 96th percentileMomentumMomentum: 14th percentileGrowthGrowth: 97th percentileValuationValuation: 23rd percentileExpectationsExpectations: 3rd percentile
676	SMMTOpen SMMT on Seeking Alpha in a new tab.19% of the way from the 52-week low to the 52-week high.	Summit TherapeuticsHealthcare Biotechnology	4	No data	Momentum: 3rd percentile	Growth: 92nd percentile	Valuation: 2nd percentile	Expectations: 11th percentile	QualityNo dataMomentumMomentum: 3rd percentileGrowthGrowth: 92nd percentileValuationValuation: 2nd percentileExpectationsExpectations: 11th percentile